
News
Benchling has partnered with Lilly TuneLab to bring AI models trained on over $1 billion in Lilly research data directly into scientists' workflows. Run prediction models for antibodies and small molecules, then share data back for federated learning — all without leaving Benchling. Reach out to your Benchling account team for access & information.
Eli Lilly created TuneLab to give biotech companies access to their proprietary drug discovery models, built from decades of research data and hundreds of thousands of experimental molecules. TuneLab levels the playing field, bringing AI capabilities that Lilly scientists use daily to companies of all sizes.
AI/ML models for in silico property predictions across small molecules and antibodies
Built on secure federated learning—your data stays private
Models continuously improve as more companies participate

Benchling is the platform where scientists already capture, connect, and analyze R&D data. TuneLab at Benchling means predictions flow directly into your existing workflows—no data exports, no context switching, no disconnected tools.
Run predictions directly from your Benchling Notebook and Registry
Results automatically linked to your sequences, molecules, and experimental metadata
Outputs are traceable and ready for downstream analysis

TuneLab expands Benchling Models, our centralized hub where scientists access the world's leading scientific AI. Alongside structure prediction models like AlphaFold, Chai, and Boltz, TuneLab brings Lilly's proprietary drug disposition and safety models directly into your workflows.
Part of Benchling AI, alongside our partnerships with Anthropic, NVIDIA, and others
One place to access open-source and proprietary scientific models
Connected to your structured data for predictions that drive decisions

Lilly chose Benchling as a priority platform partner for TuneLab distribution…Their collaborative AI model will reach scientists around the world. We're building the infrastructure that makes sophisticated AI accessible to the entire industry.
CEO and co-founder of Benchling